Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas

CONCLUSIONS: Percutaneous thermal ablation is efficient in the treatment of HCAs and may thus be considered a valid first-line treatment option. In addition, SRFA allows for an effective, minimally invasive treatment of large and multiple hepatic tumors within one session.PMID:35654476 | DOI:10.1080/02656736.2022.2082562

Source: International Journal of Hyperthermia - June 2, 2022 Category: Internal Medicine Authors: Gregor Laimer Peter Schullian Yannick Scharll Daniel Putzer Gernot Eberle Georg Oberhuber Reto Bale Source Type: research